Paper20162574
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
Zhu W and 4 others. Int J Cancer, 2010. Cited by 255 papers, by iCite.
Cite this record
ConductScience Library. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Papers, record 20162574. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20162574
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Lung Neoplasms | Major topic |
| MicroRNAs | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Stomach Neoplasms | Major topic |
| Apoptosis | |
| Cell Line, Tumor | |
| Cisplatin | |
| Down-Regulation | |
| Drug Resistance, Neoplasm | |
| Humans | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Transfection | |
| Vincristine |
Source PubMed
Cited by149
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959646 | Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42959646 | PubMed |
| 42804038 | Unraveling the Mechanisms of Chemoresistance in Gastric Cancer: Insights and Emerging Research Strategies. | Curr Oncol Rep | 2026 | https://conductscience.org/library/papers/42804038 | PubMed |
| 42089947 | Mechanisms of chemoresistance in gastric cancer: interplay between microRNAs and the tumor microenvironment. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42089947 | PubMed |
| 41088176 | The multiplex crosstalk between non-coding RNAs, programmed cell death and related mechanisms: a dynamic duo in hematological malignancies. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41088176 | PubMed |
| 40289974 | The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic Leukemia. | Curr Pharm Des | 2025 | https://conductscience.org/library/papers/40289974 | PubMed |
| 40261350 | Alternative medicines in oncology: a focus on natural products against gastric cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/40261350 | PubMed |
| 39164671 | The role of microRNAs in the gastric cancer tumor microenvironment. | Mol Cancer | 2024 | https://conductscience.org/library/papers/39164671 | PubMed |
| 38967485 | Exploiting Matrix Stiffness to Overcome Drug Resistance. | ACS Biomater Sci Eng | 2024 | https://conductscience.org/library/papers/38967485 | PubMed |
| 38384388 | Human NTHL1 expression and subcellular distribution determines cisplatin sensitivity in human lung epithelial and non-small cell lung cancer cells. | NAR Cancer | 2024 | https://conductscience.org/library/papers/38384388 | PubMed |
| 38372909 | Assessing the Potential Apoptotic Effects of Different Hydatid Cyst Fluids on Human Healthy Hepatocytes and Hepatocellular Carcinoma Cells. | Acta Parasitol | 2024 | https://conductscience.org/library/papers/38372909 | PubMed |
| 37686110 | MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686110 | PubMed |
| 37569845 | Role of microRNAs in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569845 | PubMed |
| 37535106 | Mechanism of cisplatin resistance in gastric cancer and associated microRNAs. | Cancer Chemother Pharmacol | 2023 | https://conductscience.org/library/papers/37535106 | PubMed |
| 36778005 | Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36778005 | PubMed |
| 35886942 | MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35886942 | PubMed |
| 35832555 | Targeting Adenylate Cyclase Family: New Concept of Targeted Cancer Therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/35832555 | PubMed |
| 35593587 | miR-181b regulates vascular endothelial aging by modulating an MAP3K3 signaling pathway. | FASEB J | 2022 | https://conductscience.org/library/papers/35593587 | PubMed |
| 35582270 | Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582270 | PubMed |
| 35444536 | Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35444536 | PubMed |
| 35438143 | The paradigm of drug resistance in cancer: an epigenetic perspective. | Biosci Rep | 2022 | https://conductscience.org/library/papers/35438143 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| MIR181C | 406957 | PubTator's text mining | https://conductscience.org/library/genes/406957 | NCBI Gene |
| MIR181D | 574457 | PubTator's text mining | https://conductscience.org/library/genes/574457 | NCBI Gene |
| MIR18A | 406953 | PubTator's text mining | https://conductscience.org/library/genes/406953 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20162574
GET https://conductscience.org/api/papers/v1/20162574/cited_by?page=2